Becker's Healthcare November 5, 2021
Hannah Mitchell

The FDA’s Office of Minority Health and Health Equity awarded a $3 million contract to the New Haven, Conn.-based Yale School of Medicine to study and enhance health equity in clinical trials using ambassadors and EHR data.

Four things to know:

  1. The study will focus on understanding contributing factors to mortality in minority populations, according to an Oct. 27 news release. It will use real-time COVID-19 data and EHRs to promote clinical trial data, integrate social determinants of health information at the community level, and understand how to communicate culturally appropriate COVID-19 research and awareness.
  2. Yale patients who may benefit from enrolling in a clinical trial, based on health data in their EHR, will be informed by their...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: EMR / EHR, Equity/SDOH, FDA, Govt Agencies, Health IT, Healthcare System, Technology
Related Articles:
11 drugs now in shortage
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
Pfizer hemophilia gene therapy arrives in US to uncertain future
Early tests of H5N1 prevalence in milk suggest U.S. bird flu outbreak in cows is widespread
Bird Flu (H5N1) Explained: Here’s What To Know—And Why Scientists Are Concerned

Share This Article